Vitrolife AB (publ) reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was SEK 941 million compared to SEK 905 million a year ago. Net income was SEK 143 million compared to SEK 106 million a year ago. Basic earnings per share from continuing operations was SEK 1.06 compared to SEK 0.78 a year ago.
For the six months, sales was SEK 1,782 million compared to SEK 1,759 million a year ago. Net income was SEK 258 million compared to SEK 206 million a year ago. Basic earnings per share from continuing operations was SEK 1.91 compared to SEK 1.52 a year ago.